Over 2,500 patients treated at VGH using MRSAid™

Our MRSAid™ Photodisinfection procedure has been well received at VGH and represents a promising approach to improve patient safety in other healthcare facility settings… Photodisinfection (is) ideal for hospital settings as it eliminates the need for patient compliance as it can be administered just prior to surgery- Carolyn Cross, Chairman and CEO of Ondine.

Less than a year ago, Vancouver General Hospital implemented the MRSAid™ Photodisinfection System as part of a year-long infection control Quality Improvement Project. Since then, we are very pleased to announce that we have treated over 2,500 patients, making this one of the largest PDT studies in the world. The project is being undertaken with the objective of reducing the incidence of surgical site infections in selected surgical populations.

Many people do not know that the nose is the primary site for bacteria colonization. The average person touches their nose more than 100 times a day, and if they touch their nose and then touch their surgical site, they are at risk of giving themselves an infection that was completely preventable. Many studies have demonstrated a significant reduction in surgical site infections after nasal decolonization of both Staph and MRSA. It is therefore critical to continue the development of non-antibiotic treatments that eliminate potentially deadly bacteria from the nose.

Every year in Canada, surgical site infections affect approximately 50,000 patients, costing the healthcare system over $200 million. Surgical site infections after major surgeries like cardiac or orthopedic procedures can add well over $100,000 to the cost of care for a single patient. In many cases, the presence of highly antibiotic resistant pathogens, such as MRSA, further add to patient recovery times and mortality. Patients with surgical site infections are five times more likely to be readmitted to hospital and twice as likely to die. The average SSI requires an extended hospital stay of 8 days in an acute care setting, adding millions of dollars of unnecessary costs annually to the health care system.

View our latest press releaseTo learn more about how MRSAid™ can help benefit patients and hospitals, please visit our website at www.mrsaid.com or read our latest press release.


Related Posts Plugin for WordPress, Blogger...

3 Responses to “Over 2,500 patients treated at VGH using MRSAid™”

  1. Dane Buckland says:

    This staph infection is deadly and can and does kill humans and animals. In fact, this very thing happened to Jill Moss’ most beloved white Samoyed, Bella. Jill lost Bella to this staph infection less than a year ago. It prompted Jill to take serious action and bring the knowledge of this deadly strain of bacteria to the world so that other pet owners and people would not have to suffer the loss she has. Jill has instituted the Bella Moss Foundation. ”

    Look at the most up-to-date piece of writing at our very own web site

  2. Barbara says:

    Hi there! I’m at work surfing around your blog from my new iphone 4! Just wanted to say I love reading through your blog and look forward to all your posts! Carry on the excellent work!

    my web blog … Kalaydjian Mihran *Barbara*

  3. this content says:

    Write more, thats all I have to say. Literally, it seems as though you relied on
    the video to make your point. You clearly know what youre talking about, why
    throw away your intelligence on just posting videos to your site when you could be
    giving us something informative to read?

    Check out my web blog; this content

Leave a Reply

Staypressed theme by Themocracy